COMPARISON OF IMMUNOHISTOCHEMISTRY, FISH, RTPCR METHODOLOGIES FOR DETECTION OF EML4-ALK FUSION GENE IN ADVANCED NON-SMALL CELL LUNG CARCINOMA

被引：0
作者：
Han, Xiao-hong [1 ,2 ]
Ma, Li [3 ]
Liu, Yutao [3 ]
Zhang, Ningning [3 ]
Li, Dan [3 ]
Shi, Yuankai [3 ]
机构：
[1] Chinese Acad Med Sci, Canc Hosp Inst, Med Oncol, Beijing, Peoples R China
[2] Peking Union Med Coll, Beijing, Peoples R China
[3] Canc Inst, Med Oncol, Beijing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2012年 / 7卷 / 11期
关键词：
NSCLC; Immunohistochemistry; Fluorescent in situ hybridization; RT-PCR; ALK;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O-024
引用
收藏
页码：S453 / S454
页数：2
相关论文
共 50 条
  • [31] Comparison of small biopsy specimens and surgical specimens for the detection of EGFR mutations and EML4-ALK in non-small-cell lung cancer
    Xiao, DeSheng
    Lu, Can
    Zhu, Wei
    He, QiuYan
    Li, Yong
    Fu, ChunYan
    Zhou, JianHua
    Liu, Shuang
    Tao, YongGuang
    ONCOTARGET, 2016, 7 (37) : 59049 - 59057
  • [32] Epidemiology of EML4-ALK translocations in a small, German non-small-cell lung cancer patient cohort
    Schildgen, Verena
    Lochl, Vincenza
    Luesebrink, Jessica
    Brockmann, Michael
    Schildgen, Oliver
    PERSONALIZED MEDICINE, 2012, 9 (08) : 801 - 803
  • [33] Frequency and clinical relevance of EGFR mutations and EML4-ALK translocations in octogenarians with non-small cell lung cancer
    Tufman, Amanda
    Kahnert, Kathrin
    Duell, Thomas
    Kauffmann-Guerrero, Diego
    Milger, Katrin
    Schneider, Christian
    Stump, Julia
    Syunyaeva, Zulfiya
    Huber, Rudolf Maria
    Reu, Simone
    ONCOTARGETS AND THERAPY, 2017, 10 : 5179 - 5186
  • [34] EML4-ALK Fusion Detected by RT-PCR Confers Similar Response to Crizotinib as Detected by FISH in Patients with Advanced Non-Small-Cell Lung Cancer
    Wang, Yan
    Zhang, Jun
    Gao, Guanghui
    Li, Xuefei
    Zhao, Chao
    He, Yayi
    Su, Chunxia
    Zhang, Shijia
    Chen, Xiaoxia
    Zhang, Jie
    Li, Wei
    Li, Bing
    Zhao, Jing
    Hou, Likun
    Wu, Chunyan
    Ren, Shengxiang
    Zhou, Caicun
    Zhang, Jun
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (11) : 1546 - 1552
  • [35] Exon scanning by reverse transcriptase-polymerase chain reaction for detection of known and novel EML4-ALK fusion variants in non-small cell lung cancer
    Sanders, Heather R.
    Li, Hai-Rong
    Bruey, Jean-Marie
    Scheerle, Jay A.
    Meloni-Ehrig, Aurelia M.
    Kelly, JoAnn C.
    Novick, Constance
    Albitar, Maher
    CANCER GENETICS, 2011, 204 (01) : 45 - 52
  • [36] Performance of a RT-PCR Assay in Comparison to FISH and Immunohistochemistry for the Detection of ALK in Non-Small Cell Lung Cancer
    Hout, David R.
    Schweitzer, Brock L.
    Lawrence, Kasey
    Morris, Stephan W.
    Tucker, Tracy
    Mazzola, Rosetta
    Skelton, Rachel
    McMahon, Frank
    Handshoe, John
    Lesperance, Mary
    Karsan, Aly
    Saltman, David L.
    CANCERS, 2017, 9 (08)
  • [37] Sensitive and specific detection of EML4-ALK rearrangements in non-small cell lung cancer (NSCLC) specimens by multiplex amplicon RNA massive parallel sequencing
    Moskalev, Evgeny A.
    Frohnauer, Judith
    Merkelbach-Bruse, Sabine
    Schildhaus, Hans-Ulrich
    Dimmler, Arno
    Schubert, Thomas
    Boltze, Carsten
    Koenig, Helmut
    Fuchs, Florian
    Sirbu, Horia
    Rieker, Ralf J.
    Agaimy, Abbas
    Hartmann, Arndt
    Haller, Florian
    LUNG CANCER, 2014, 84 (03) : 215 - 221
  • [38] Expression of Protein Kinase EML4-ALK Gene in Non-Small Cell Lung Cancer (NSCLC) in a University Hospital of Reference in Latin America
    Sua, Luz F.
    Fernandez, Liliana
    Munoz, Carlos A.
    Restrepo, Juan G.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S696 - S696
  • [39] Ensartinib as a neoadjuvant therapy for stage IIIA non-small cell lung cancer patients with EML4-ALK fusion: a case report and literature review
    Zhang, Hao
    Xia, Wei
    Zhang, Yifan
    Bao, Shihao
    Zeng, Jingtong
    Li, Xianjie
    Zhang, Bo
    Wang, Hanqing
    Xu, Song
    Song, Zuoqing
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [40] Impact of EML4-ALK Variants and TP53 Status on the Efficacy of ALK Inhibitors in Patients With Non-small Cell Lung Cancer
    Zou, Zihua
    Wu, Lige
    Hao, Xuezhi
    Li, Yan
    Liang, Li
    Gu, Yangchun
    Ying, Jianming
    Li, Junling
    Xing, Puyuan
    THORACIC CANCER, 2025, 16 (02)
12345